Hypothyroxinemia During Gestation and Offspring Schizophrenia in a National Birth Cohort

Biological Psychiatry

Volumn 79, Issue 12, 2016, Pages 962-970

  Gyllenberg, David ^a,b   Sourander, Andre ^a,b,c   Surcel, Heljä Marja ^d   Hinkka Yli Salomäki, Susanna ^b   McKeague, Ian W ^e   Brown, Alan S ^a,e  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b University of Turku   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e Department of Medicine   (United States)

Author keywords

Biomarker; Cohort; Neurodevelopment; Prenatal; Schizophrenia; Thyroid

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CHILDBIRTH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FINLAND; FIRST TRIMESTER PREGNANCY; FREE THYROXINE INDEX; HOSPITAL PATIENT; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MATERNAL SMOKING; MEDICAL HISTORY; OUTPATIENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; RESIDENTIAL HOME; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SECOND TRIMESTER PREGNANCY; SEX; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHILD; DEFICIENCY; GESTATIONAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; FEMALE; FINLAND; GESTATIONAL AGE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES; SCHIZOPHRENIA; THYROXINE; YOUNG ADULT;

EID: 84937140958     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.06.014     Document Type: Article

References (51)

1. 1 Henrichs, J., Ghassabian, A., Peeters, R.P., Tiemeier, H., Maternal hypothyroxinemia and effects on cognitive functioning in childhood: How and why?. Clin Endocrinol (Oxf) 79 (2013), 152–162.
2. 2 Zoeller, R.T., Rovet, J., Timing of thyroid hormone action in the developing brain: Clinical observations and experimental findings. J Neuroendocrinol 16 (2004), 809–818.
3. 3 Gilbert, M.E., Rovet, J., Chen, Z., Koibuchi, N., Developmental thyroid hormone disruption: Prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology 33 (2012), 842–852.
4. 4 Auso, E., Lavado-Autric, R., Cuevas, E., Del Rey, F.E., Morreale De Escobar, G., Berbel, P., A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 145 (2004), 4037–4047.
5. 5 de Escobar, G.M., Obregon, M.J., del Rey, F.E., Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 18 (2004), 225–248.
6. 6 Calvo, R.M., Jauniaux, E., Gulbis, B., Asuncion, M., Gervy, C., Contempre, B., et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87 (2002), 1768–1777.
7. 7 Haddow, J.E., Palomaki, G.E., Allan, W.C., Williams, J.R., Knight, G.J., Gagnon, J., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341 (1999), 549–555.
8. 8 Willoughby, K.A., McAndrews, M.P., Rovet, J.F., Effects of maternal hypothyroidism on offspring hippocampus and memory. Thyroid 24 (2014), 576–584.
9. 9 Pop, V.J., Kuijpens, J.L., van Baar, A.L., Verkerk, G., van Son, M.M., de Vijlder, J.J., et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 50 (1999), 149–155.
10. 10 Li, Y., Shan, Z., Teng, W., Yu, X., Fan, C., Teng, X., et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf) 72 (2010), 825–829.
11. 11 Henrichs, J., Bongers-Schokking, J.J., Schenk, J.J., Ghassabian, A., Schmidt, H.G., Visser, T.J., et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: The generation R study. J Clin Endocrinol Metab 95 (2010), 4227–4234.
12. 12 Welham, J., Isohanni, M., Jones, P., McGrath, J., The antecedents of schizophrenia: A review of birth cohort studies. Schizophr Bull 35 (2009), 603–623.
13. 13 Canetta, S., Sourander, A., Surcel, H.M., Hinkka-Yli-Salomäki, S., Leiviska, J., Kellendonk, C., et al. Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am J Psychiatry 171 (2014), 960–968.
14. 14 M'kikyro, T., Isohanni, M., Moring, J., Hakko, H., Hovatta, I., Lönnqvist, J., Accuracy of register-based schizophrenia diagnoses in a genetic study. Eur Psychiatry 13 (1998), 57–62.
15. 15 Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21 (2011), 1081–1125.
16. 16 Männisto, T., Surcel, H.M., Ruokonen, A., Vaarasmaki, M., Pouta, A., Bloigu, A., et al. Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population. Thyroid 21 (2011), 291–298.
17. 17 Männisto, T., Surcel, H.M., Bloigu, A., Ruokonen, A., Hartikainen, A.L., Järvelin, M.R., et al. The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: Implications for analyzing samples stored in serum banks. Clin Chem 53 (2007), 1986–1987.
18. 18 van Os, J., Kapur, S., Schizophrenia. Lancet 374 (2009), 635–645.
19. 19 Cannon, M., Jones, P.B., Murray, R.M., Obstetric complications and schizophrenia: Historical and meta-analytic review. Am J Psychiatry 159 (2002), 1080–1092.
20. 20 Brown, A.S., The environment and susceptibility to schizophrenia. Prog Neurobiol 93 (2011), 23–58.
21. 21 Haddow, J.E., McClain, M.R., Lambert-Messerlian, G., Palomaki, G.E., Canick, J.A., Cleary-Goldman, J., et al. Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy. J Clin Endocrinol Metab 93 (2008), 3341–3347.
22. 22 Kooistra, L., Crawford, S., van Baar, A.L., Brouwers, E.P., Pop, V.J., Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 117 (2006), 161–167.
23. 23 Craig, W.Y., Allan, W.C., Kloza, E.M., Pulkkinen, A.J., Waisbren, S., Spratt, D.I., et al. Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years. J Clin Endocrinol Metab 97 (2012), E22–E28.
24. 24 Männisto, T., Vaarasmaki, M., Pouta, A., Hartikainen, A.L., Ruokonen, A., Surcel, H.M., et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 95 (2010), 1084–1094.
25. 25 Cleary-Goldman, J., Malone, F.D., Lambert-Messerlian, G., Sullivan, L., Canick, J., Porter, T.F., et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 112 (2008), 85–92.
26. 26 Official Statistics of Finland (2015): Population structure. Available at: http://tilastokeskus.fi/til/vaerak/kas_en.html. Accessed May 6, 2015.
27. 27 Hernan, M.A., Hernandez-Diaz, S., Robins, J.M., A structural approach to selection bias. Epidemiology 15 (2004), 615–625.
28. 28 Greenland, S., Modeling and variable selection in epidemiologic analysis. Am J Public Health 79 (1989), 340–349.
29. 29 Rothman, K., Lash, T.L., Greenland, S., Modern Epidemiology. 3rd ed., 2012, Lippinicott Williams & Wilkins, Philadelphia.
30. 30 Stagnaro-Green, A., Pearce, E., Thyroid disorders in pregnancy. Nat Rev Endocrinol 8 (2012), 650–658.
31. 31 Rapoport, J.L., Giedd, J.N., Gogtay, N., Neurodevelopmental model of schizophrenia: Update 2012. Mol Psychiatry 17 (2012), 1228–1238.
32. 32 Insel, T.R., Rethinking schizophrenia. Nature 468 (2010), 187–193.
33. 33 Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. The nuclear receptor superfamily: The second decade. Cell 83 (1995), 835–839.
34. 34 Bernal, J., Guadano-Ferraz, A., Morte, B., Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 13 (2003), 1005–1012.
35. 35 Alvarez-Dolado, M., Ruiz, M., Del Rio, J.A., Alcantara, S., Burgaya, F., Sheldon, M., et al. Thyroid hormone regulates reelin and dab1 expression during brain development. J Neurosci 19 (1999), 6979–6993.
36. 36 Lavado-Autric, R., Auso, E., Garcia-Velasco, J.V., Arufe Mdel, C., Escobar del Rey, F., Berbel, P., et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 111 (2003), 1073–1082.
37. 37 Harrison, P.J., The hippocampus in schizophrenia: A review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174 (2004), 151–162.
38. 38 Negro, R., Formoso, G., Mangieri, T., Pezzarossa, A., Dazzi, D., Hassan, H., Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab 91 (2006), 2587–2591.
39. 39 MacSweeney, D., Timms, P., Johnson, A., Thryo-endocrine pathology, obstetric morbidity and schizophrenia: Survey of a hundred families with a schizophrenic proband. Psychol Med 8 (1978), 151–155.
40. 40 Zimmermann, M.B., The effects of iodine deficiency in pregnancy and infancy. Paediatr Perinat Epidemiol 26:suppl 1 (2012), 108–117.
41. 41 Brucker-Davis, F., Panaia-Ferrari, P., Gal, J., Fenichel, P., Hieronimus, S., Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. Eur Thyroid J 2 (2013), 187–194.
42. 42 Erkkola, M., Karppinen, M., Jarvinen, A., Knip, M., Virtanen, S.M., Folate, vitamin D, and iron intakes are low among pregnant Finnish women. Eur J Clin Nutr 52 (1998), 742–748.
43. 43 Schaefer, C.A., Brown, A.S., Wyatt, R.J., Kline, J., Begg, M.D., Bresnahan, M.A., et al. Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophr Bull 26 (2000), 275–286.
44. 44 Klaning, U., Mortensen, P.B., Kyvik, K.O., Increased occurrence of schizophrenia and other psychiatric illnesses among twins. Br J Psychiatry 168 (1996), 688–692.
45. 45 Sirugo, G., Ashenbrenner, J., Odunsi, K., Morakinyo, O., Page, G., No evidence of association between the genetic predisposition for dizygotic twinning and schizophrenia in West Africa. Schizophr Res 70 (2004), 343–344.
46. 46 Gejman, P.V., Sanders, A.R., Kendler, K.S., Genetics of schizophrenia: New findings and challenges. Annu Rev Genomics Hum Genet 12 (2011), 121–144.
47. 47 Craddock, N., Owen, M.J., The Kraepelinian dichotomy—going, going … but still not gone. Br J Psychiatry 196 (2010), 92–95.
48. 48 Roman, G.C., Ghassabian, A., Bongers-Schokking, J.J., Jaddoe, V.W., Hofman, A., de Rijke, Y.B., et al. Association of gestational maternal hypothyroxinemia and increased autism risk. Ann Neurol 74 (2013), 733–742.
49. 49 Brown, A.S., Surcel, H., Hinkka-Yli-Salomaki, S., Cheslack-Postava, K., Bao, Y., Sourander, A., Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort. Prog Neuropsychopharmacol Biol Psychiatry 57 (2015), 86–92.
50. 50 Cannon, M., Clarke, M.C., Cotter, D.R., Priming the brain for psychosis: Maternal inflammation during fetal development and the risk of later psychiatric disorder. Am J Psychiatry 171 (2014), 901–905.
51. 51 Giovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339 (2013), 1095–1099.